Case TS-09A4DF9120 Oct 2026regulatoryCompound claim

Beauty

“Korean pharmacies sell creams containing 20% azelaic acid and 4% hydroquinone over-the-counter without a prescription.”

Plain restatementIn South Korea, topical creams formulated at 20% azelaic acid and at 4% hydroquinone are classified so that they can be bought in pharmacies without a doctor's prescription.

Mostly accurateConfidence High
What this verdict means →

General information only - not medical or dermatological advice.

This one checks out, with a caveat about what "over the counter" means in Korea. South Korea's drug regulator lists a 20% azelaic acid cream and 4% hydroquinone creams as non-prescription medicines, so a pharmacy can sell them without a doctor's prescription. The caveat is that these are registered medicines, not cosmetics: they are sold by a pharmacist inside a pharmacy rather than on a shop shelf, not every pharmacy stocks them, and Korean reporting describes 4% as the upper limit for hydroquinone sold this way, with stronger versions needing a prescription. Many other countries, including the United States, treat hydroquinone as prescription-only, so availability genuinely differs by country. What the regulator's listing establishes is what may be sold in Korea, not who should use these strengths or for how long; the hydroquinone label itself carries cautions including pregnancy and children under 12. Rules and classifications change, so this reflects the position as of 20 October 2026. General information only, not medical or dermatological advice.

The drift / as claimed vs as evidenced

[drifted from the evidence:] Korean pharmacies sell creams [drifted from the evidence:] containing 20% azelaic acid and 4% hydroquinone [drifted from the evidence:] over-the-counter without a prescription.


[added by the neutral restatement:] In South Korea, topical creams [added by the neutral restatement:] formulated at 20% azelaic acid and [added by the neutral restatement:] at 4% hydroquinone [added by the neutral restatement:] are classified so that they can be bought in pharmacies without a [added by the neutral restatement:] doctor's prescription.

Red-tinted words in the claim drifted from the evidence. Green-tinted words are what a neutral restatement needs.

The trace / claim to source

Where it appeared
Secondary sourceprofessional drug information body
Korea Pharmaceutical Information Center (health.kr) entry for 아젤리아크림: azelaic acid 200 mg/g, 전문/일반 = 일반 (non-prescription), ATC D10AX03
Secondary sourcemarketing authorisation holder
Dong-A Pharmaceutical product page for 멜라노사크림: 일반의약품, hydroquinone (USP) 40 mg, "available at pharmacies"
Secondary sourcepress of record, for the event only
Financial News (fnnews), 2026-10-06: GC Green Cross launched 아젤라힐크림, a domestically made azelaic acid acne cream approved in July as a 일반의약품, purchasable at neighbourhood pharmacies without a prescription
Secondary sourcespecialist health press
Health Kyunghyang (k-health.com) feature on pigmentation treatment: states hydroquinone at 4% or below is classified as 일반의약품 and above 4% as 전문의약품 (prescription)
Primary sourcenational regulator of record (Korea MFDS)
MFDS drug product register (nedrug), entry for 아젤리아크림 (Azelia Cream, azelaic acid), item code 200608046: azelaic acid 200 mg per 1 g, classification 일반의약품 (non-prescription medicine), approval 2006-11-24
Primary sourcenational regulator of record
MFDS drug product register (nedrug), entry for 멜라노사크림 (Melanosa Cream, hydroquinone), item code 201105515: hydroquinone 40 mg per 1 g, dosing stated as 4%, classification 일반의약품, approval 2011-08-24
Primary sourcenational regulator of record
MFDS drug product register (nedrug), entry for 하이토닝크림 (hydroquinone), item code 202302167: classification 일반의약품, approval 2023-07-14
● Primary source found
What is true
  • Korea's drug register lists a 20% azelaic acid cream, Azelia Cream at 200 mg per gram, in the 일반의약품 class, which is the class that may be bought without a prescription.
  • Korea's drug register lists 4% hydroquinone creams, Melanosa Cream at 40 mg per gram and 하이토닝크림, in the same non-prescription class.
  • Both strengths are therefore obtainable in a Korean pharmacy without a doctor's prescription, which is the substance of the claim.
  • The 20% azelaic acid position is current, not historical: a further domestic azelaic acid cream was approved as a non-prescription medicine and launched in October 2026 with the same pharmacy-without-prescription route.
  • Both strengths sit above what many other markets allow without a prescription, including the United States, where the FDA's consumer material states that skin products containing hydroquinone should be used only when prescribed by a licensed provider.
What is misleading
  • "Pharmacies sell" is right, but the word "creams" invites a reader to picture cosmetics. These are authorised medicines in Korea's 일반의약品 class, sold by a pharmacist behind the counter, not cosmetic products on an open shelf. Korean consumer coverage notes that many pharmacies do not stock them and advises checking by phone first.
  • The claim gives 4% hydroquinone as a free-standing fact. Korean specialist health press describes 4% as the top of the non-prescription band, with higher strengths requiring a prescription, so the figure is a regulatory ceiling rather than an open allowance.
  • Read in the context of a travel post, the claim can be taken as a statement about what a visitor should buy. The register entries establish what is authorised for sale in Korea; they say nothing about whether a given person should use these strengths, and the Melanosa label itself carries contraindications including pregnancy and children aged 12 and under.
  • The phrasing "20% azelaic acid and 4% hydroquinone" could be read as one cream containing both. The register shows two separate single-active products.
What is uncertain
  • Whether the 4% cut-off between non-prescription and prescription hydroquinone is set in a binding MFDS classification notice or is a description of the authorised products that happen to exist. The sources found state the rule but are not the instrument.
  • Whether purchase requires any pharmacist counselling step or sale record in practice, which the register entries do not address.
  • Whether the status of either ingredient has been amended since the approval dates shown. The entries retrieved carry approval dates, and the October 2026 launch indicates the azelaic acid position was current that month, but no amendment history was retrieved.
Evidence summary

The Korean regulator's own product register contains marketing authorisations for both formulations the claim names. Azelia Cream is authorised at 200 mg azelaic acid per gram, which is 20%, and is classified 일반의약품, the Korean category for a medicine that may be sold without a prescription. Melanosa Cream is authorised at 40 mg hydroquinone per gram, which is 4%, with directions to apply "as 4% hydroquinone once or twice daily," and is likewise classified 일반의약품. A second 4% hydroquinone cream, 하이토닝크림, carries the same classification with a 2023 approval. A further azelaic acid 20% product from a domestic manufacturer was approved as 일반의약품 and launched in October 2026, with press coverage stating explicitly that it can be bought at local pharmacies without a prescription. Two conditions sit behind that classification and are not in the claim. First, 일반의약품 is a medicine category, not a cosmetic one: these tubes are sold inside pharmacies by a pharmacist, not on open shelves at cosmetic retailers, and stocking is reported to be patchy, with Korean consumer coverage advising callers to phone ahead. Second, the non-prescription status is concentration-bounded for hydroquinone: specialist Korean health press states that 4% or below is non-prescription and above 4% is prescription-only, so 4% is at the ceiling rather than an arbitrary strength.

Complete reasoning
The Korean regulator's own product register carries both formulations at the exact strengths claimed, each classified 일반의약품, the category sold without a prescription, and a further 20% azelaic acid product entered that route in October 2026. "Accurate" was considered and set aside because the claim omits that these are pharmacy-counter medicines rather than cosmetics, that stocking is uneven, and that 4% is the top of the non-prescription band for hydroquinone, simplifications that do not change the central point but do shape what a reader expects to find. "Partially accurate but misleading" was considered and rejected because nothing in the claim reverses a status or transfers a rule from another country; the direction and the numbers both hold. Confidence is High because the primary register entries were retrieved and state the concentration and the classification directly; the only unresolved items, the wording of the classification threshold and the cosmetic-side status, do not bear on whether the claim is right.
Use this case

The reply is formatted for pasting into the thread where the claim is circulating.

Ask this case

Answers come only from the case file above; nothing is added.

Is it true you can buy 20% azelaic acid and 4% hydroquinone creams at Korean pharmacies without a prescription?

Yes. South Korea's drug register classifies both a 20% azelaic acid cream (Azelia Cream) and 4% hydroquinone creams (Melanosa Cream and 하이토닝크림) as 일반의약품, the category that can be sold without a doctor's prescription.

Can I just pick these up off a shelf like a regular cosmetic?

No. These are registered medicines, not cosmetics, so they are sold by a pharmacist inside a pharmacy rather than displayed on an open shelf. Korean consumer coverage also notes that not every pharmacy stocks them, so it is worth calling ahead.

Is 4% the strongest hydroquinone you can get without a prescription in Korea?

Based on Korean specialist health press, yes, 4% is described as the upper limit for non-prescription hydroquinone, with anything stronger requiring a prescription.

Does this mean these strengths are safe for anyone to use?

The case file does not establish that. The register entries only show what can legally be sold in Korea, and the Melanosa label itself carries cautions, including against use during pregnancy and in children aged 12 and under.

Is this rule guaranteed to still apply if I check again later?

The investigation could not confirm whether the 4% cut-off is set by a binding regulatory notice or simply reflects the products currently approved, and no amendment history was found. The information reflects the position as of 20 October 2026.

Mostly accurate: In South Korea, topical creams formulated at 20% azelaic acid and at 4% hydroquinone are c… | TrueSeeker